Faculty, Staff and Student Publications
Publication Date
1-1-2024
Journal
Clinical Parkinsonism & Related Disorders
Abstract
•Early differentiation between PD and atypical parkinsonism is challenging.•Variability in diagnosis can weaken statistical power in trials.•Precise diagnostic tools are needed for trial population homogeneity.•This patient initially diagnosed with PD, was diagnosed with MSA via CSF αSyn-SAA.•Adding αSyn-SAA to inclusion criteria could enhance subject selection in trials.
Keywords
Clinical trial, Alpha-synuclein, Parkinson’s disease, Multiple System Atrophy
DOI
10.1016/j.prdoa.2024.100274
PMID
39963592
PMCID
PMC11832018
PubMedCentral® Posted Date
10-5-2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes